Spravato Insurance Denied? How to Appeal Your Esketamine Depression Denial

Spravato (esketamine) is a fast-acting nasal spray FDA-approved for treatment-resistant depression (TRD) and major depressive disorder with acute suicidal ideation or behavior (MDD-ASIB). It provides rapid relief — often within hours to days — making it critically important for patients who have not responded to multiple antidepressants. Despite this urgent clinical need, insurance denials for Spravato are extremely common. Here's how to fight back.

What Spravato Treats and Why Patients Need It

Spravato works through a completely different mechanism than conventional antidepressants. As an NMDA receptor antagonist, esketamine rapidly boosts glutamate signaling, which quickly restores synaptic connections lost through chronic depression. Traditional SSRIs and SNRIs target serotonin and norepinephrine and can take 6–8 weeks to show effect — if they work at all.

FDA-approved indications:

• Treatment-resistant depression (TRD) in adults: defined as MDD that has failed to respond to at least two different antidepressants of adequate dose and duration
• Major depressive disorder with acute suicidal ideation or behavior (MDD-ASIB) in adults, as a short-term treatment

For TRD patients who have cycled through multiple antidepressants over months or years without relief, Spravato represents a fundamentally different therapeutic option that can break the cycle. For MDD-ASIB patients, rapid response can be life-saving.

Spravato is administered in a certified healthcare setting (REMS program) under observation for at least 2 hours after each dose — a fact that supports its legitimacy as a supervised medical treatment rather than a drug of abuse.

Common Denial Reasons for Spravato

Insufficient number of failed antidepressants: Most plans require documented failure of at least two adequate trials of antidepressants before approving Spravato for TRD. Some plans require more — up to four failed trials.

Inadequate trial duration or dose: Plans may deny because prior antidepressant trials were "not adequate" — either too short in duration (less than 4–6 weeks at therapeutic dose) or at sub-therapeutic doses.

Covered only for TRD, not MDD-ASIB: Some plans cover Spravato for TRD but not for the acute suicidal ideation indication, or have unclear coverage for the ASIB indication.

Setting of care requirements: Because Spravato must be administered in a certified healthcare setting, Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization often requires documentation of the treatment site's REMS certification.

Mental health step therapy: Plans may require electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) before approving Spravato.

Step-by-Step: How to Appeal a Spravato Denial

Step 1: Get the denial reason in writing. Identify whether the denial is about the number of failed antidepressants, trial duration, the specific indication (TRD vs. ASIB), or coverage of the treatment setting.

Step 2: Document your antidepressant history meticulously. For each prior antidepressant: drug name, dose, duration (weeks or months), reason for failure (non-response, partial response, adverse effects). Two or more adequate trials are the typical TRD definition.

Step 3: Have your psychiatrist write a comprehensive Letter of Medical Necessity. The LMN should document TRD diagnosis, chronological antidepressant history, current symptom severity (PHQ-9 score), suicide risk assessment if applicable, and why Spravato is the appropriate next step.

Step 4: If ECT or TMS is required as a step, either document those trials or have your psychiatrist explain why they are contraindicated or inappropriate for this patient.

Step 5: Confirm the treatment site is REMS-certified. If this is a documentation issue, verify REMS certification and include it.

Step 6: File the internal appeal and request peer-to-peer review with a psychiatrist.

Step 7: File an external appeal if the internal appeal is denied. For mental health coverage, federal mental health parity laws add additional grounds for appeal.

What to Include in Your Spravato Appeal Letter

• Policy number, member ID, and claim reference
• Indication: TRD or MDD-ASIB (specify which)
• PHQ-9 or other validated depression severity score
• Chronological antidepressant trial history: drug, dose, duration, outcome
• Suicide risk assessment documentation if MDD-ASIB indication
• Documentation of prior augmentation strategies (lithium, atypical antipsychotics, thyroid hormone)
• REMS-certified treatment site documentation
• Letter of Medical Necessity from psychiatrist
• FDA approval citations for TRD and MDD-ASIB indications
• TRANSFORM trial citations (Phase 3 esketamine data)
• Mental health parity arguments if applicable
• Request for peer-to-peer review

Success Tips for Spravato Appeals

Document trials as "adequate." An antidepressant trial is considered adequate when it is at an appropriate therapeutic dose (not the starting dose) for at least 4–6 weeks. If a prior trial was discontinued early due to adverse effects, note this clearly and explain it represents a genuine trial failure, not inadequate compliance.

Lead with the urgency of TRD. Treatment-resistant depression carries an enormous burden — unemployment, disability, relationship breakdown, substance use, and significantly elevated suicide risk. Make the stakes clear in your appeal.

Invoke mental health parity. Under the Mental Health Parity and Addiction Equity Act (MHPAEA), insurance plans cannot impose more restrictive treatment limitations on mental health conditions than on comparable medical conditions. If the plan requires more failed medication trials for Spravato than for analogous medical conditions, this may constitute a parity violation.

Use the MDD-ASIB pathway for urgent cases. If suicidal ideation is current and documented, the MDD-ASIB indication has a different approval basis that may bypass some of the TRD step therapy requirements.

Fight Back With ClaimBack

Treatment-resistant depression can rob people of their quality of life for years. Spravato offers a new pathway when nothing else has worked. If your insurer denied it, ClaimBack can help you build an urgent, comprehensive appeal.

Start your Spravato appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Common Reasons Insurance Claims Are Denied